Genius Sports Ltd. (GENI) Insider Trading

Last 12 months

Insiders sold $5.58M and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Chief Executive Officer Mark Locke sold $5.26M on Sep 17 outside a plan. No executive or director has bought shares on the open market in the last two years.

Net open-market

−$5.58M

0 buys · 2 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 2

executives and directors

Last open-market buy

None

in the last two years

Get an email when GENI's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 17	Thomas Russell Chief Legal Officer	SoldNo plan	50,000	$6.51	$326k	9.6%	Form 4
Sep 15 – 17	Mark Locke Chief Executive Officer	SoldNo plan 3 parts	800,000	$6.57 average	$5.26M	4.0%	Form 4

Sep 17No plan
Thomas Russell
Chief Legal Officer · sold 50,000 at $6.51
$326k
9.6% of stake
Sep 15 – 17No plan
Mark Locke
Chief Executive Officer · sold 800,000 at avg $6.57
$5.26M
4.0% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch GENI, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-Miscellaneous Amusement & Recreation

GDENNew Royal Holdco I Inc.

PRSUPursuit Attractions and Hospitality

SEATVivid Seats Inc.

MSGEMadison Square Garden Entertainment Corp.

MSGSMadison Square Garden Sports Corp.

RSIRush Street Interactive Inc.

SEGSeaport Entertainment Group, Inc.

BUKSButler National Corporation

Spot a number that looks wrong? Check it in GENI's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing GENI

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.